Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...

Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...

Daphne Koller, founder and CEO of Insitro, has secured major partnerships with pharmaceutical giants like Eli Lilly and Bristol Myers Squibb to advance A.I.-powered drug discovery. Courtesy of Insitro ...